GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (OTCPK:SNBIF) » Definitions » Cyclically Adjusted PB Ratio

SanBio Co (SanBio Co) Cyclically Adjusted PB Ratio : 3.56 (As of Jun. 20, 2024)


View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Cyclically Adjusted PB Ratio?

As of today (2024-06-20), SanBio Co's current share price is $3.85. SanBio Co's Cyclically Adjusted Book per Share for the quarter that ended in Apr. 2024 was $1.08. SanBio Co's Cyclically Adjusted PB Ratio for today is 3.56.

The historical rank and industry rank for SanBio Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SNBIF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 9.86
Current: 9.86

During the past years, SanBio Co's highest Cyclically Adjusted PB Ratio was 9.86. The lowest was 0.00. And the median was 0.00.

SNBIF's Cyclically Adjusted PB Ratio is ranked worse than
89.06% of 658 companies
in the Biotechnology industry
Industry Median: 1.665 vs SNBIF: 9.86

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

SanBio Co's adjusted book value per share data for the three months ended in Apr. 2024 was $0.227. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.08 for the trailing ten years ended in Apr. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


SanBio Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for SanBio Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Cyclically Adjusted PB Ratio Chart

SanBio Co Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SanBio Co Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 3.56

Competitive Comparison of SanBio Co's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, SanBio Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SanBio Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where SanBio Co's Cyclically Adjusted PB Ratio falls into.



SanBio Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

SanBio Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=3.85/1.08
=3.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SanBio Co's Cyclically Adjusted Book per Share for the quarter that ended in Apr. 2024 is calculated as:

For example, SanBio Co's adjusted Book Value per Share data for the three months ended in Apr. 2024 was:

Adj_Book=Book Value per Share/CPI of Apr. 2024 (Change)*Current CPI (Apr. 2024)
=0.227/107.7000*107.7000
=0.227

Current CPI (Apr. 2024) = 107.7000.

SanBio Co Quarterly Data

Book Value per Share CPI Adj_Book
201401 -0.495 95.500 -0.558
201410 0.000 98.200 0.000
201501 -0.019 97.800 -0.021
201504 1.383 98.400 1.514
201507 1.259 98.300 1.379
201510 1.285 98.500 1.405
201601 1.207 97.700 1.331
201604 1.248 98.100 1.370
201607 1.141 97.900 1.255
201610 1.028 98.600 1.123
201701 0.887 98.200 0.973
201704 0.713 98.500 0.780
201707 0.473 98.300 0.518
201710 0.281 98.800 0.306
201801 0.169 99.500 0.183
201804 0.691 99.100 0.751
201807 1.950 99.200 2.117
201810 1.818 100.200 1.954
201901 1.644 99.700 1.776
201904 1.446 100.000 1.557
201907 2.476 99.800 2.672
201910 2.267 100.400 2.432
202001 1.932 100.500 2.070
202004 1.747 100.200 1.878
202007 1.633 100.000 1.759
202010 1.559 99.800 1.682
202101 1.554 99.800 1.677
202104 1.222 99.100 1.328
202107 0.973 99.700 1.051
202110 0.665 99.900 0.717
202201 0.342 100.300 0.367
202204 0.354 101.500 0.376
202207 0.483 102.300 0.508
202210 0.190 103.700 0.197
202301 0.530 104.700 0.545
202304 0.444 105.100 0.455
202307 0.243 105.700 0.248
202310 0.192 107.100 0.193
202401 0.281 106.900 0.283
202404 0.227 107.700 0.227

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SanBio Co  (OTCPK:SNBIF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


SanBio Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of SanBio Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SanBio Co (SanBio Co) Business Description

Industry
Traded in Other Exchanges
Address
8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (SanBio Co) Headlines

From GuruFocus

Full Year 2023 SanBio Co Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2021 SanBio Co Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2024 SanBio Co Ltd Earnings Presentation Transcript

By GuruFocus Research 02-15-2024

Q2 2019 SanBio Co Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2021 SanBio Co Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2022 SanBio Co Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024